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Introduction
Nicotine in tobacco products is highly addictive with significant adverse health consequences.
Once smokers become addicted (approximately 1,200 per day in the United States), they have great difficulty quitting 1 . In addition to conventional cigarettes, cigars and water pipes, devices environment where the rat can move freely during a long-term study. The volume for the rat freemoving space of the cylindrical chamber was around 6.7 L.
Determinations of the aerosol droplet size distribution and mass concentration in air in the rat exposure chamber
The nicotine aerosol generation and exposure system was set up in a fume hood at temperature of 22 ± 1°C. Nicotine (freebase) was dissolved in NaCl solution or water for an osmolality ~300 mOsm/kg. An Aerodynamic Particle Sizer (APS; model 3321, TSI Inc. Shoreview, MN, USA) was used to measure the droplet size distribution of nicotine aerosol generated from nicotine solution at different concentrations in the jar of the nebulizer. Total sampling airflow rate of APS was 5 L/min.
The sampling tube was located around the center above the platform where the rat is expected to stay on.
Mass concentrations of the nicotine aerosol were measured with a one-stage cascade impactor
(SKC Inc. Eighty Four, PA, USA). Before the assay, the filters for the impactor were balanced in a temperature (22 °C) and humidity (49%) controlled environment where the electronic balance (Mettler-Toledo MX5 Microbalance, Mettler-Toledo Inc. Columbus, OH, USA) for weighing the filters was located. The filter weight difference between pre-and post-nicotine aerosol collection is the mass collected in a preset duration. Gravimetric filter sampling was conducted at sampling airflow rate of 2 L/min for 5 min in each experimental scenario.
Nicotine aerosol exposure and blood sample collection
For blood sample collection, femoral artery catheterized rats were ordered from Harlan/Envigo Co (Indianapolis, IN, US).
For exposure accuracy, only one rat was put into each sealed exposure chamber. The device was programed to generate nicotine aerosol every half hour, for a total of 24 times in every 12-hour dark phase of 12/12-hour dark/light circadian cycles for 10 days. When the nicotine aerosol delivery pause (the time intervals between aerosol deliveries), fresh air from the pressurized air source was supplied to the chamber at a rate of 60 air change per hr (AC/h) adjusted with one of . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/195123 doi: bioRxiv preprint first posted online Sep. 27, 2017;  the two flow meter. 30-35 ml nicotine solution was put in the nebulizer jar and the solution was replaced with fresh one every day. Rats were returned to their home cage where no nicotine aerosol was delivered during the 12-hr light phrase.
For blood collection, the rat was put into a rat holder (Model #: CHT-250, CH Technologies Inc.
Westwood, NJ, USA). Blood samples (equivalent to 0.1 ml plasma) were collected at a series of time points (see Results section) on day 3 and day 10. The blood was collected from the opening of the exteriorization tubing of the catheter into a 0.6-ml capillary blood collection tube containing 
Measurements of plasma nicotine and cotinine concentrations
Plasma samples containing nicotine and cotinine were extracted using solid phase extraction method. In brief, 50 μL of internal standard (Nicotine-d3 10 μg/mL) was added to 50 μL plasma.
Then 600 μL of 10% trichloroacetic acid was added to acidify the plasma sample. After centrifuging at 13,000 rpm for 5 min, supernatant was loaded onto pre-conditioned MCX SPE cartridge (Part # 186000252, Waters, USA). Cartridge was washed using 0.5 mL of 2% formic acid followed by 0.5 mL of methanol, and then analytes were eluted by 2X0.5 mL of methanol with 5% ammonium hydroxide. The eluted analytes were neutralize using 10 μL of 0.02 N HCl, and the samples were evaporated using a steady stream of dried and filtered nitrogen gas. Dried samples were reconstituted with 50 μL of mobile phase buffer and 40 μL was injected to LC-MS for analysis.
The concentrations of nicotine and its metabolite cotinine were quantified using a validated Liquid chromatography-tandem mass spectrometry (LC-MS/MS). The LC-MS/MS system consists of an API4000 triple quadrapole mass spectrometer (AB Sciex, USA) linked to Shimadzu LC-20AD HPLC (Shimadzu, Japan). All the analytes were detected by using multiple reaction monitoring in positive mode, where Q1Q3 is 163.2117.1 for nicotine, 177.280.1 for cotinine, and . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/195123 doi: bioRxiv preprint first posted online Sep. 27, 2017;  These data suggest that the droplet size distribution depends on the physical properties of the solution and the nebulizer air pressure, as solutions with higher nicotine concentrations are higher in viscosity and lower in vapor pressure. Under a wide range of experimental conditions, rodents in the free-moving chamber were exposed to nicotine aerosol with respirable droplet size that can get into the alveolar region of the lungs.
Next we determined the nicotine aerosol concentrations in air in the breathing zone of the freemoving rodent chamber. As shown in Table 1 The droplet size distributions and mass concentrations were similar at different location in the cylindrical exposure chamber except the very corners of the cylinder.
These results indicate that our system can deliver a wide range of amounts of nicotine quickly into the circulation of rodents through inhalation route in a free-moving cage. The nicotine dose can be readily controlled by altering the nicotine solution concentrations in the nebulizer or other aerosol generation parameters, i.e., air pressure in the nebulizer. Our data can serve as a guide for choosing parameters in nicotine aerosol inhalation experiments for researchers to develop rodent models simulating human tobacco and E-cig smoking.
Chronic intermittent nicotine aerosol (CINA) inhalation exposure in rats produces circadian blood PK resembling human smokers
The parameters of aerosol generation including nicotine concentrations in the solution in the nebulizer, the air pressure entering the nebulizer, the duration and interval of aerosol deliveries were adjusted and optimized based on measurements of nicotine and cotinine levels in the plasma of exposed rats. A solution of 0.1% nicotine in 0.9% NaCl (adjusted to pH 8.0 with HCl) was put in the container of the nebulizer. We delivered nicotine aerosol in a schedule of once every 30 min for a total of 24 deliveries in every 12-hr dark phase of 12/12-hr dark/light circadian cycles for 10 days. The duration of nicotine aerosol delivery was 1 min except the 1 st daily aerosol delivery which was 2 min in order to boost the nicotine level from the lowest level at the beginning of the .
CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/195123 doi: bioRxiv preprint first posted online Sep. 27, 2017; dark phase. We previously reported that acute nicotine aerosol inhalation produces a quick rise in arterial blood nicotine levels followed by a slower decline. The arterial nicotine levels decrease to a level close to that of venous blood in ~30 min 17 .
On day 3 and day 10, we collected blood samples every two hrs by the end of the 29 min intervals between aerosol deliveries when arterial nicotine level is similar to that of venous blood during the 12-hr dark phase, and every 4 hrs during the 12-hr light phase (when there was no nicotine aerosol exposure). As shown in Fig. 2 , plasma nicotine concentrations gradually increased during the 12-hr dark phase, reaching a peak of 30-35 ng/ml in 8-12 hr from the start of the daily nicotine aerosol deliveries, with a slower rising of cotinine levels reaching 190-240 ng/ml. Nicotine levels gradually decreased to 5-10 ng/ml and cotinine to 70-100 ng/ml during the light phase. There was no significant difference between day 3 and day 10. Summary nicotine PK parameters are listed in Table 2 . Area under the concentration-time curve (AUC0-24hrs) indicates daily total systemic nicotine exposure in our CINA inhalation exposure conditions.
These data indicate that the circadian fluctuation patterns of blood nicotine and cotinine levels in our rat model are similar to the circadian blood (venous) PK of human smokers 21 , with an exception of lower nicotine and cotinine levels by the end of the light phase, which is consistent with the notion that nicotine metabolism is faster in rats compared to humans 22 . The circadian PK was stabilized from day 3 and consistent throughout the CINA treatment period of 10 days, suggesting a balance of nicotine intake vs. elimination and metabolism under our experimental conditions.
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